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Abstract
White Spot Syndrome Virus (WSSV) is an infectious pathogen of shrimp and other crustaceans, and neither effective
vaccines nor adequate treatments are currently available. WSSV is an enveloped dsDNA virus, and one of its major envelope
proteins, VP28, plays a pivotal role in WSSV infection. In an attempt to develop a vaccine against WSSV, we inserted the
VP28 gene into a baculovirus vector tailored to express VP28 on the baculovirus surface under the WSSV ie1 promoter (Bac-
VP28). The Bac-VP28 incorporated abundant quantity (65.3 mg/ml) of VP28. Shrimp were treated by oral and immersion
vaccination with either Bac-VP28 or wild-type baculovirus (Bac-wt). The treatment was followed by challenge with WSSV
after 3 and 15 days. Bac-VP28 vaccinated shrimp showed significantly higher survival rates (oral: 81.7% and 76.7%;
immersion: 75% and 68.4%) than Bac-wt or non-treated shrimp (100% mortality). To verify the protective effects of Bac-
VP28, we examined in vivo expression of VP28 by immunohistochemistry and quantified the WSSV copy number by qPCR. In
addition to that, we quantified the expression levels shrimp genes LGBP and STAT by real-time RT-PCR from the samples
obtained from Bac-VP28 vaccinated shrimp at different duration of vaccine regime. Our findings indicate that oral
vaccination of shrimp with Bac-VP28 is an attractive preventative measure against WSSV infection that can be used in the
field.
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Introduction
With a high economic output—US$ 9.0 billion annually—
shrimp culture plays a major role in global aquaculture [1]. The
successful production of shrimp is hampered by several viral
diseases, particularly White Spot Syndrome Virus (WSSV). It has
been one of the most threatening infectious pathogens to the
shrimp culture industry over the past two decades. WSSV-related
cumulative mortality typically reaches 100% within 2 to 5 days of
the onset of clinical signs. The virus has a wide host range that
includes freshwater prawns, lobsters, freshwater crabs and several
species of marine crabs [2,3,4,5]. WSSV belongs to the genus
Whispovirus (www.ncbi.nih.gov/ICTVdb/Ictv/index.htm) under
the viral family Nimaviridae. It is a rod-shaped, enveloped dsDNA
virus approximately 275 nm in length and 120 nm in width with
tail-like appendages at one end. Sequencing of the full genome of
WSSV revealed that it has 184 ORFs, but the role of many of its
viral proteins is still unknown. As of this study, 39 structural
proteins have been identified in WSSV, including 22 envelope
proteins [6]. The WSSV genome contains at five known major
structural proteins: VP28, VP19, VP26, VP24 and VP15. Studies
on WSS viral proteins have demonstrated that VP28 and VP19
are associated with the virion envelope. VP26 acts as a tegument
protein linking the two nucleocapsid-associated proteins VP24 and
VP15 to the envelope [7].
Novel viral control strategies, including vaccination, are
necessary due to the continued high growth of shrimp cultivation
and the broad host range of WSSV. Invertebrates lack a true
adaptive immune response and rely solely on an innate immune
response, so until recently, vaccination of shrimp against WSSV
was not considered a viable strategy. However, Venegas et al. [8]
demonstrated the existence of quasi-immune response in Penaeus
japonicus that had survived previous exposure to WSSV. In another
study, shrimp became resistant to WSSV about 3 weeks after
infection and hemolymph from resistant shrimp contained
virus neutralizing factors [9]. These results stimulated research
into the possibility of vaccinating shrimp against WSSV. Within
a few years, numerous published studies explored different
WSSV vaccination strategies to protect shrimp, including
inactivated WSSV vaccines [10,11], subunit recombinant vaccines
[12,13,14,15], oral recombinant vaccines [16,17], DNA vaccines
[18,19,20] and dsRNA [21,22].
In most WSSV vaccines, VP28 has been a major target, as the
envelope structural proteins of WSSV play a pivotal role in initial
viral infection. The envelope proteins are often necessary for viral
budding, entry and assembly. VP28 is a major envelope protein of
WSSV and is involved in the systemic infection of shrimp [23,24].
During WSSV infection, VP28 interacts with host cellular proteins
such as PmRab7 [25], heat shock cognate protein 70 [26] and the
signal transducer and activator of transcription (STAT) [27] to
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ed that VP28-based recombinant vaccines provide protection and
increase the survival rate of challenged shrimp during WSSV
experiments when compared with unvaccinated shrimp
[10,15,16,17]. However, the protection offered by these VP28
derived recombinant vaccines is not high, and the protective
response is drastically low at 10 days post-challenge. It may be
possible to improve vaccine efficacy by expressing the recombinant
VP28 protein in a baculovirus eukaryotic expression system.
In the present study, we inserted VP28 gene into baculoviral
vector under the control of the WSSV ie1 promoter and expressed
VP28 gene (Bac-VP28) on baculovirus surface. Our quantitative
western blotting technique showed, abundant quantity of VP28
was expressed on Bac-VP28. Next, we demonstrate for the first
time an efficacious immunisation of WSSV immersion-challenged
shrimp by administering Bac-VP28 via oral and immersion routes.
The protective response generated in Bac-VP28 immunized
shrimp against WSSV was measured by quantification of WSSV
viral copy numbers by quantitative real-time PCR (qPCR) and
in vivo expression of VP28 by immune histochemistry (IHC). To
authenticate vaccine efficacy we quantified shrimp Lipopolysac-
charide and b-1,3-glucan binding protein (LGBP) and STAT
genes expression profiles by real-time RT-PCR from the samples
obtained from vaccinated shrimp at different duration of vaccine
regime. Hence, Bac-VP28 is an attractive preventative measure for
shrimp culture against WSSV infection that can be used in the
field applicable approach.
Materials and Methods
Collection and maintenance of experimental animals
Shrimp, Penaeus monodon (10–12 g body weight), were imported
from Malaysia and maintained in 1000-l fiberglass tanks with air-
lift biological filters at an ambient temperature of 27–30uC with
salinity between 20 and 25 ppt. Natural seawater was used in all
the experiments. It was pumped from the adjacent sea to
Singapore and allowed to sediment to remove the sand and other
suspended particles. The seawater was then chlorinated by treating
with sodium hypochlorite at the concentration of 25 ppm and then
dechlorinated by vigorous aeration, before being passed through a
sand filter and used for the experiments. The animals were fed
with artificial pellet feed (BTA feed, Malaysia). Temperature and
pH were recorded, salinity was measured with a salinometer
(Aquafauna, Japan) and dissolved oxygen was estimated by the
Winkler method. The animals were kept in tanks for 5 days and
acclimatized prior to the experiments. From the experimental
animals, 5 from a group of 30 were randomly selected and
screened for the presence of WSSV by polymerase chain reaction
(PCR) using the primers designed by Takahashi et al. [28] and
only healthy shrimp were used for the experiments.
Preparation of WSSV viral inoculum
The laboratory WSSV stock was used in this study and it was
propagated by injecting into healthy shrimp. The hemolymph was
drawn directly from the hearts of moribund shrimp using sterile
syringesfollowed bycentrifugation(30006gfor20 minat4uC).The
supernatant fluid was then re-centrifuged (80006 g for 30 min at
4uC) and the final supernatant fluid was filtered through a 0.4 mm
filter. The filtratewasthen stored at280uC for experimental studies.
Generation of recombinant baculovirus
For the construction of VP28 gene into pFASTBacHT A (life
technologies, USA) baculovirus transfer vector contains polyhedrin
promoter including His tag, ATG and multiple cloning sites was
replaced with WSSV ie1 promoter with RsrII and HindIII
restriction enzymes. The ie1 promoter was amplified from WSSV
DNA using the primers WSSVie1F-59-CCTACGTATCAATTT-
TATGTGGCTAATGGAGA-39and WSSVie1R-59-CGCGTC-
GACCTTGAGTGGAGAGAGAGCTAGTTATAA-39 then in-
serted into pFASTBacHT A using AccI and RsrII restriction site.
The full length ORF of VP28 gene was amplified from WSSV
genome using the primers Bac-VP28F 59-CGCCGGTCCGATG-
GATCTTTCTTTCACTCTTTC-39 and Bac-VP28R 59-CCG-
AAGCTTTTACTCGGTCTCAGTGCCAG-39 with RsrII and
HindIII restriction enzymes and cloned into modified pFAST-
BacHT A vector.
For the generation of recombinant baculoviruses the constructs
were integrated into the baculovirus genome within DH10Bac
TM
(life technologies, USA) through site-specific transposition accord-
ing to the protocol of Bac-to-Bac system (life technologies). The
recombinant baculoviruses with VP28 gene was named as Bac-
VP28 and without VP28 gene was known as Bac-wt. Further
recombinant baculovirus were propagated in SF-900II SFM (life
technologies) at 27uC and infecting Sf9-cells as described by Syed
Musthaq et al. [29].
Immunofluorescence assay to detect the expression of
VP28 in insect cells
To detect the Immunofluorescence signals, Sf9 cells were grown
in 24 well plates and infected with Bac-VP28 and Bac-wt
baculovirus at a MOI of 0.5. After 48 hrs post infection, the cells
were fixed with paraformaldehyde for 20 min and blocked with
1% gelatin for 30 min at room temperature. The fixed cells were
then incubated with anti-mouse PrVP28 (prokaryotic expressed
recombinant VP28) polyclonal antibody prepared by Syed
Musthaq et al. [29] at a dilution of 1:100 for 1 hr at 37uC.
FITC-conjugated rabbit anti-mouse (DakoCytomation, Denmark)
at a dilution of 1:100 was subsequently incubated with the cells for
1 hr. The fluorescence signal was detected with an inverted
fluorescence microscope (Olympus, UK) and the images were
captured by a digital imaging system (Nikon, USA).
Western blot analysis of VP28
For Western blot analysis, the Bac-VP28 infected cells or
supernatant were mixed with Laemmli sample buffer and SDS-
PAGE was carried out as described by Laemmli [30]. VP28 from
purified WSSV virions served as a reference while Bac-wt was
included as a negative control. The gel was transferred to
nitrocellulose membrane and Western blot was performed by
the method of Talbot et al. [31]. The anti-mouse PrVP28
polyclonal antibodies at a dilution of 1:2000 were used as primary
antibody and rabbit anti-mouse IgG (DakoCytomation, Denmark)
at a dilution of 1:1000 were used as secondary antibody to detect
the baculovirus expression of VP28.
Quantitative western blotting
Odyssey Infrared Imager (LI-COR, Biotechnology) was used to
calculate the amount of VP28 present on recombinant baculo-
virus. The PrVP28 expressed in bacterial system and purified with
His-tag fusion partner was used as a standard. The anti-mouse
VP28 polyclonal antibodies at the dilutions of 1:2000 and a
dilution of 1:10,000 of donkey anti-mouse IRdye800CW IgG (LI-
COR, Biotechnology) was used as primary and secondary
antibody respectively. The membrane was developed and band
intensities were analysed by Odyssey Application software version
1.2. The amount of VP28 displayed on Bac-VP28 was calculated
by comparing with PrVP28 as standard control.
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Oral vaccination. For the oral vaccination experiment,
commercial shrimp pellet feed weighing 2 g were coated with
3m lo f1 610
8 pfu/ml of baculovirus containing Bac-VP28, Bac-
wt and positive, negative control pellets were coated with
phosphate buffer saline (PBS). The feed was mixed and
incubated on ice for 30 min followed by room temperature (RT)
incubation for 30 min to allow absorption. The pellets were coated
with fish oil to prevent dispersion of the baculovirus or PBS in
water. A batch of shrimp was divided into four groups and 20
shrimps per group were selected. The shrimp in group first and
second were administrated orally with Bac-VP28 and Bac-wt
coated feed continuously for 7 days, whereas group third and
fourth were administrated orally with PBS coated feed. Third day
after final vaccination, the shrimp in group one to three were
immersed in a sea water containing a dilution of 1:150 WSSV
stock solution for 2 hrs, then the shrimp was changed in to fresh
seawater without WSSV, whereas group four was challenged with
PBS containing seawater. Another batch of shrimp (4 groups, 20
shrimp each group), the vaccine experiment was repeated and
shrimp were challenged with WSSV on 15 days post vaccination
(dpv), whereas group 4 was challenged with PBS. The oral
vaccination experiments were repeated three times.
Immersion vaccination. In the vaccination experiment, a
batch of shrimp was divided into four groups and 20 shrimps per
group were selected. The shrimp in group first and second were
immersed in 2 liters of seawater containing 3 ml 1610
8 pfu/ml of
Bac-VP28 and Bac-wt respectively for 2 hr, whereas the third and
fourth groups were immersed in seawater containing 1 ml of PBS.
The immersion vaccination was repeated another 2 times at 5 day
intervals. Third day after final vaccination, the shrimp in group
one to three were immersed in a sea water containing a dilution of
1:150 WSSV stock solution for 2 hrs, then the shrimp was
changed in to fresh seawater without WSSV, whereas group four
was challenged with PBS. In another batch of shrimp (4 groups, 20
shrimp each group), the vaccine experiment was repeated and
shrimp were challenged with WSSV on 15 dpv, whereas group 4
was challenged with PBS. The immersion vaccination experiments
were repeated three times.
In vivo expression of VP28
Immuno histochemistry analysis was performed to evaluate the
in vivo expression of VP28 at the translational level. The shrimp
tissues (eye stalk and hepatopancrease) were collected from Bac-
VP28 and Bac-wt vaccinated shrimp at 7 dpv and was fixed in
10% buffer formalin. After 48 hr, the samples were processed and
embedded in paraffin wax using Embedder (Leica, Germany),
then sectioned into 4 mm thickness using microtome (Leica
Autocut microtome model 2255, Leica Microsystems, Wetzlar,
Germany). The sections were de-paraffinized using Histo-choice
(Amersco, Solon, Ohio, USA) and rehydrated in sequentially
graduated ethanol baths to distilled water. The sections were
treated with trypsin (0.1% w/v in PBS) for 10 min and washed
twice with PBS-Tween 20 (0.01% v/v with PBS). Slides were
blocked in 0.1% non fat milk in PBS for 30 min followed by
incubation with anti-mouse PrVP28 polyclonal antibody at a
dilution of 1:100 for 1 h at room temperature. Slides were then
washed 3 times in PBS-T and incubated with HRP-conjugated
rabbit anti-mouse (DakoCytomation, Denmark) at a dilution of
1:50 for 30 min. After washing, the sections were mounted using
glycerol. The slides were observed under a microscope (Olympus,
UK) and the images were captured by digital imaging system
(Nikon, USA).
Quantification of WSSV by real-time PCR
Quantitative real-time PCR was performed to determine the
WSSV viral loads in shrimp tissues samples collected at 2, 5, 7, 10
and 15 days of post infection (dpi). The viral copy number was
estimated by using Rotor Gene Q (Qiagen Inc., USA) using
DyNAmo
TMSYBRH Green qPCR Kit (Finnzymes, Espoo, Fin-
land). Briefly, the primers QVP26F-59-ATCTCTACCGTCACA-
CAGCC-39 and QVP26R-59-GAAGATTTTAATGTCCTTGC-
TCG-39 was used to amplify a 211-bp fragment from the VP26
gene of WSSV. Viral DNA was isolated from 50 mg of gill tissue
by using the QIAamp DNA tissue kit (Qiagen Inc., USA)
according to the manufacturer’s instructions. DNA was resus-
pended in 50 ml of DNase-RNase-proteinase-free water. The PCR
parameters consisted of 40 cycles of denaturation at 94uC for
10 sec, annealing at 58uC for 5 sec, and extension at 72uC for
10 sec. A standard curve was obtained using serial dilutions of
plasmid pVP26 (full length ORF of VP26 gene of WSSV was
cloned into pQE-30 vector) were used to quantify the WSSV viral
genomic copy number. The geometric mean of viral genomic
copies per reaction was calculated for each group after setting
results for negative samples to one copy per sample. Each assay
was carried out in triplicate.
Quantification of LGBP and STAT genes expression by
real-time RT-PCR
Real-time RT-PCR was carried out to quantify the mRNA
expressions of shrimp LGBP and STAT genes from healthy or
WSSV infected and Bac-VP28 vaccinated shrimp’s hepatopan-
creas tissue collected at 2, 5, 7, 10 and 15 dpi. Briefly, the total
RNA was extracted by Trizol method following the manufactur-
er’s protocol (life technologies, USA) and RNA quality and
quantity was determined by Nanodrop spectrophotometer ND-
1000. DNA contamination was removed by using RNase free
DNase I (Fermentas Inc, USA) and synthesis of cDNA was
performed with oligo dT primer (Roche, USA) and cDNA
conversion mix (Promega, USA) as per manufacturer’s instruc-
tions. The amplifications were performed by using Rotor Gene Q
(Qiagen Inc., USA) real time PCR machine using DyNAmo
TM-
SYBRH Green qPCR Kit (Finnzymes, Espoo, Finland) with
cDNAs of respective genes. The highly gene specific quantitative
real-time RT-PCR primers targeting LGBP gene [32] and STAT
gene [33] were used to analysis the expression levels of LGBP and
STAT genes in experimental shrimp tissues. Briefly, the following
primers were used in this study, for LGBP gene (289-170F-
59GGTAACCAGTACGGAGGAACGA93), (289-233R -59TAC-
TCGACGTGGGTCTTCTCGA93) and for STAT gene (390F-
59AGCCCCTGTCTGAGCGAAA93), (461R- 59GGTGTTCT-
CTTGTGACCTTCATCA93). For all real-time assays, internal
control gene, shrimp EF-1a (elongation factor) specific primers
were used and described by Roux et al. [32]. The thermal profile
for SYBR Green RT-PCR was 50uC for 2 min and 95uC for
10 min followed by 40 cycles of 95uC for 15 s and 60uC for 1 min.
The dissociation curve of each PCR product was a single peak and
each sample was run in triplicate along with an internal con-
trol gene. The SYBR Green assay was repeated three times
independently. The DDCt method was used to monitor the
transcription level of shrimp LGBP and STAT target genes. The
Ct values of amplified target genes (CtLGBP &C t STAT) and internal
control gene (CtEF-1a) in each sample were computed by relative
quantification method described in Rotor Gene Q. DCt values
were then calculated by subtracting CtEF-1a from CtSTAT or
CtLGBP. To normalize the data, DCt for each tested samples
(CtSTAT or CtLGBP) was subtracted from the average DCt of the
calibrator (PBS- injected to shrimp), to produce a value called
Recombinant Baculovirus Vaccination against WSSV
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the transcription level of the calibrator was then expressed as
2
2DDCt. The data obtained from this real time PCR were
subjected to a T-test where p-values below 0.05 were considered
to be significant.
Statistical analysis
The values are expressed as arithmetic mean 6 SD. The level of
significance was expressed as P,0.01. The protection against
WSSV after vaccination was calculated as the relative percent
survival (RPS) (1-mortality of vaccinated group/mortality of
control group)6100 [34].
Results
Generation of recombinant baculovirus and its
confirmation
The WSSV genome encoding envelope protein VP28 was
selected for the generation of recombinant baculovirus with an
immediate early promoter 1 (ie1) derived from the WSSV genome
and named as Bac-VP28 (Fig. 1a). The above construct without
VP28 gene is termed as Bac-wt (Fig. 1a). The recombinant
baculoviruses are generated in Sf9-II cells and followed the
method described by Bac-to-Bac expression system (life technol-
ogies, USA). The expression of VP28 was analyzed by Immuno-
flourescence assay and results indicated that baculovirus counter
part VP28 expressed in insect cells and maintains its structural and
antigenic conformity (Fig. 1b). Next, we compared the molecular
mass of VP28 present in the baculovirus infected cell lysate or
complete virion and purified WSSV virions by the western blot
analysis, which detected a band both with the similar size of
28 kDa (Fig. 1c) with anti-mouse PrVP28 polyclonal antibody.
However, neither fluorescent signal nor specific product was
detected in Bac-wt derived from insect cells or lysate.
Quantitative western blotting
For the quantification of VP28 displayed on Bac-VP28, we
carried out quantitative western blotting technique using Odyssey
Infrared Imager (LI-COR, Biotechnology). The VP28 protein
concentration presents in Bac-VP28 was compared with PrVP28
expressed in E.coli system as standard control and results were
analysed by Odyssey Application software version 1.2. From the
Figure 1. Schematic structure of recombinant baculovirus construct, analysis the expression of VP28 on baculovirus system using
anti-mouse VP28 polyclonal antibodies and Quantification of VP28 expressed from Bac-VP28. (a) The VP28 gene was cloned
downstream of WSSV ie1 promoter and upstream of Tsv40 of pFasBacHT vector and named as Bac-VP28 and above construct with out VP28 gene
named as Bac-wt. (b) Immunofluorescence assay of expression of VP28 in Sf9 cells. The cells were infected with Bac-VP28 and Bac-wt at MOI of 0.5
and at 48 hrs post infection the cells fixed and analysed. (c) Western blot analysis of baculovirus expressed VP28 compared with WSSV virions. Lane 1-
supernatant of baculovirus expressed VP28; Lane 2-complete Bac-VP28 virions; Lane 3-complete Bac-wt virions; Lane 4-purified wild type WSSV
virions from WSSV infected shrimp tissue. (d) (i) -quantitative western blot analysis of VP28 expressed in baculovirus system and compared with
different concentration of PrVP28 expressed in bacterial system as a standard. Lane 1 to Lane 6- purified PrVP28 protein from 0.01 mg, 0.05 mg, 0.1 mg,
0.25 mg, 0.5 mg and 1 mg; Lane Bac-VP28-1 mg total protein; Lane Bac-wt-1 mg of total protein. The nitrocellulose membrane was scanned and
analysed by Odyssey Infrared Imager. (ii)-rVP28 protein standard curve; (iii)-the amount of VP28 protein presents in Bac-VP28 culture.
doi:10.1371/journal.pone.0026428.g001
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measured on the average of 65.3 mg/ml (10
8 pfu) obtained from
three independent batches of baculovirus culture (Fig. 1d).
Vaccination experiment and WSSV challenge
Oral vaccination. In this experiment, the efficacy of surface
displayed recombinant baculovirus (Bac-VP28) was tested through
oral administration method. Two batches of shrimp contain four
groups each (20 shrimp per group) were selected as indicated in
Table 1. The shrimp in batch I, (group 1, and 2) was administrated
orally with Bac-VP28 and Bac-wt coated feed for 7 days con-
tinuously and group 3 received PBS. After vaccination, the shrimp
ingroup 1 to 3 ofbatch I was subsequentlychallenged with a WSSV
by immersion route at 3 dpv. Whereas, the same groups of shrimp
in batch II was administrated with Bac-VP28 or Bac-wt or PBS
coated feed for 7 days and challenged with WSSV at 15 dpv.
Experimental shrimp were observed twice a day and the resulting
time-mortality relationship is shown in Fig. 2a. A significantly lower
cumulative mortality of 18.3% and 23.3% (relative survival of
81.7% and 76.7% ) was observed in Bac-VP28 vaccinated shrimpat
3 dpv and 15 dpv respectively, when compared to positive control
or Bac-wt group showed a cumulative mortality of 100% at 9 to
10 dpi. Whereas the negative control groups showed no mortality
throughout the experimental period. These results are consistent
with an independent experiment, resulting Bac-VP28 vaccinated
group showed significantly higher survival rate compared Bac-wt or
positive control group.
Immersion vaccination. In this experiment, the potential of
surface displayed recombinant baculovirus was tested immersion
method. Two batches of shrimp contain four groups each (20
shrimp per group) were selected as indicated in Table 1. The
shrimps in batch I (group 1 and 2) were given through immersion
with Bac-VP28 and Bac-wt and group 3 received PBS. After
vaccination, the shrimp in group 1 to 3 of batch I was subsequently
challenged with a WSSV by immersion route at 3 dpv. Whereas,
the same groups of shrimp in batch II was administrated with Bac-
VP28 or Bac-wt or PBS and challenged with WSSV at 15 dpv.
Experimental shrimp were observed twice a day and the resulting
time-mortality relationship is shown in Fig. 2b. A significantly
lower cumulative mortality of 25% and 31.6% (relative survival of
75% and 68.4%) was observed in Bac-VP28 vaccinated shrimp at
3 dpv and 15 dpv respectively, when compared to positive control
or Bac-wt group showed a cumulative mortality of 100% at 9 to
10 dpi. Whereas the negative control groups showed no mortality
throughout the experimental period. These results are consistent
with an independent experiment, and Bac-VP28 vaccinated group
showed significantly higher survival rate compared Bac-wt or
positive control group.
In vivo expression of VP28 in shrimp
To analysis in vivo delivery capacity of WSSV ie1 based Bac-
VP28 or Bac-wt baculoviruses and expression of VP28 measured
by immunohistochemistry from the organs of vaccinated shrimp at
7 dpv. The results concealed that the Bac-VP28 was transduced
effectively and the expression of VP28 protein was observed in the
shrimp tissues eyestalk and hepatopancreas at 7 dpv (Fig. 3b).
Quantification of WSSV by real-time PCR
The WSSV infected organs from the groups of vaccinated
shrimp were collected for the quantification of WSSV viral copy
numbers by SYBR green PCR at different days post infection. The
results revealed that, viral copy numbers were increased in the
groups of shrimps till 5 dpi, later the copy numbers in Bac-VP28
shrimp was significantly reduced to 5.44610
10 WSSV copies
mg21 on 7 dpi, then dropped to 1.36610
10 WSSV copies mg
21
on 15 dpi (Fig. 3a). Whereas the viral copy numbers in Bac-wt or
positive control groups reached its peak level of 9.89610
10 WSSV
copies mg
21 and more on 9 dpi and later the shrimp were died.
Statistically significant difference has been observed at 7 dpi.
There is no viral copy numbers or change has been observed in
negative control group in experimental period.
Quantification of LGBP and STAT genes expression by
real-time RT-PCR
Real-time RT-PCR was used to quantify, the changes in
expression levels shrimp LGBP and STAT genes obtained from
the tissues of normal shrimp or WSSV infected shrimp and
compared with Bac-VP28 vaccinated shrimp tissues at different
dpi. Data were expressed as DCt and changes in the transcription
levels in LGBP and STAT genes of Bac-VP28 vaccinated relative
to WSSV infected shrimp was shown in Fig. 4. The expression
level of STAT gene in WSSV control group downregulated in
various dpi samples as infection progresses, whereas vaccinated
group showed decreasing trends of STAT gene till 7 dpi and
changes to increasing level as infection by WSSV low due to
recombinant baculoviruses. The values at 10 dpi and 15 dpi were
statistically significant. The expression levels of LGBP gene in
WSSV group upregulated as infection progress, whereas, vacci-
nated group showed increasing trend at early infections and slows
down as WSSV infection cleared by Bac-VP28. Statistically
significant difference was observed, where LGBP gene expression
was decreases in vaccinated group at 7 dpi and 10 dpi (Fig. 4).
Discussion
In the current study, we demonstrate for the first time an
efficacious immunisation of WSSV immersion-challenged shrimp
by administering Bac-VP28 via oral and immersion routes. In a
previous study, we described how vaccination with a recombinant
baculovirus surface displaying VP28 (Bac-VP28) elicited a
significantly higher survival rate as compared with other forms
of vaccination [29]. We chose the immersion method because the
challenge pressure can be well controlled, and it is the natural
infection mechanism in shrimp culture. The VP28 gene was
inserted into a baculoviral vector under the control of the WSSV
ie1 promoter (Fig. 1a). Previously, the ie1 promoter has been
shown to have efficient activity in Spodoptera frugiperda (Sf9-II) insect
Table 1. Set up for vaccination experiments.
Experiment
Name Groups Vaccine/Coating
No. of shrimp/
group
Oral vaccination Bac-VP28 Baculovirus
expressed VP28
2063
Bac-wt wild type
baculovirus
2063
Positive control PBS 2063
Negative control PBS 2063
Immersion
vaccination
Bac-VP28 Baculovirus
expressed VP28
2063
Bac-wt wild type
baculovirus
2063
Positive control PBS 2063
Negative control PBS 2063
doi:10.1371/journal.pone.0026428.t001
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between insect and mammalian cells [35]. The ie1 promoter is
active during the early stage of baculovirus infection of insect cells.
The expression of VP28 was analysed by immunofluorescence
assay, and the results indicated that VP28 is expressed in the insect
cells and maintains both its structural and antigenic conformity
(Fig. 1b). Interestingly, western blot analysis revealed that both
baculovirus-expressed VP28 and the VP28 purified from WSSV
virion particles migrated with similar sizes in SDS-PAGE (Fig. 1c).
The result indicates that the posttranslational modification of
VP28 in insect cells is similar to what occurs in shrimp cells. In
addition, we demonstrated that VP28 is present on the baculovirus
surface during its budding process and is incorporated into the
baculovirus envelope [29]. Next, we quantified the amount of
VP28 displayed on Bac-VP28 and was calculated by comparing
with PrVP28 standard control. The results showed that VP28 in
Bac-VP28 was on the average 65.3 mg/ml (10
8 pfu) from three
independent batches of baculovirus culture (Fig. 1d) and
concluded that, abundant quantity of VP28 is expressed on the
surface of the Bac-VP28.
In the present vaccination experiment, Bac-VP28 derived
vaccination conferred significantly higher survival rates of 81.7%
and 76.7% (cumulative mortality of 18.3% and 23.3%) on shrimp
challenged at 3 and 15 dpv, respectively, by oral vaccination
(Fig. 2a), and a survival rate of 75% and 68.4% (cumulative
mortality of 25% and 31.6%) on shrimp challenged at 3 and
15 dpv, respectively, by immersion vaccination (Fig. 2b). The
positive control and Bac-wt group showed a cumulative mortality
Figure 3. Analysis of the protection generated by recombinant baculovirus by (a) quantification of WSSV viral copies by real-time
PCR (b) immunohistochemistry analysis of in vivo expression of VP28 from Bac-VP28 and Bac-wt vaccinated shrimp tissues. In Figure
a, each column represents the mean of triplicate assay with standard deviation. Asterisks denote significant differences (P,0.01) between samples.
All shrimp in the 10 dpi and 15 dpi samples of Bac-wt, Positive control group were died and data is Not Detectable. In Figure b, the arrow marks
indicates the expression of VP28 in shrimp tissues.
doi:10.1371/journal.pone.0026428.g003
Figure 2. Time-mortality relationship of (a) oral and (b) immersion vaccinations and WSSV challenge experiment. Shrimp were
vaccinated with Bac-VP28, Bac-wt or PBS (positive control) and challenged with WSSV or PBS buffer (negative control) on 3 and 15 days post
vaccination (dpv).
doi:10.1371/journal.pone.0026428.g002
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showed no mortality throughout the experimental period. These
results are consistent with results we obtained in a separate
experiment of the vaccination regimen in which the Bac-VP28
vaccinated group had a significantly higher survival rate than
either the Bac-wt or positive control groups. Inferring from the
VP28 quantitation, each shrimp consumed approximately 10.6 mg
of VP28 from Bac-VP28 coated feed during the course of
vaccination experiment. The quantity of VP28 delivered in this
study correlates with previous subunit vaccination experiments
with purified rVP28 against WSSV [15,18], but the protection
rate generated by recombinant baculovirus vaccination is
significantly higher. The other studies on oral vaccination with
rVP28 expressed in bacteria followed by inactivation, as vaccine
candidate lacks rVP28 quantitation data [16,17].
The Bac-VP28 vaccine demonstrated higher efficacy than
bacterially expressed VP28 protein vaccination [16,17], adminis-
tration of DNA vaccines encoding the VP28 gene [19,20] or
bacterially expressed VP28 dsRNA administration [21,22]. Shrimp
fed with bacterially over-expressed VP28-coated feed demonstrated
64% and 77% relative survival when challenged on 3 and 7 dpv,
but the protection was reduced significantly after 14 dpv [16]. In
another study, crayfish fed orally with rVP28 protein-coated feed
had a cumulative mortality of 43.2% at 3 dpv [17]. These studies
also indicated that the maximum protection time conferred by a
recombinant protein vaccine synthesised from bacteria was only in
the first 2 weeks post-vaccination. For crayfish immunised orally
with a Salmonella typhimurium encapsulated DNA vaccine plasmid
encoding the VP28 gene, there was a survival rate of 66.7% at
15 dpv [20]. Rajeshkuamr et al. [19] demonstrated a 65% survival
rate at 15 dpv for shrimp vaccinated with a chitosan nanoparticle
encapsulated DNA vaccine plasmid encoding the VP28 gene.
Sarathi et al. [22] observed a 68% survival rate for shrimp fed with
bacteriallyexpressedVP28dsRNA-coatedfeed and challengedwith
WSSV 5 dpv. However, the practical application of such DNA-
based vaccines or dsRNA to aquaculture species is limited, as they
have been found to be effective only when delivered via gene gun,
scarification [36] or, in the case of DNA vaccines, short-pulse
ultrasound [37]. When the results of the present study are
compared, the immersion vaccine method is more expensive, and
the generated pathogen protection rate is lower than what is
observed following than oral vaccination. Therefore, oral vaccina-
tion is the more convenient and inexpensive method, and it may be
the only practical way to deliver potential vaccines to the cultured
aquatic animals. Hence, the ability of baculovirus displaying VP28
to elicit an increased protection rate in vaccinated shrimp makes
baculovirus a better vaccine candidate than other current forms of
WSSV vaccination. Also, we considered to choose oral delivered
Bac-VP28 shrimp tissues are optimum choice to monitor vaccine
efficacy by other molecular assays.
To further verify the protection conferred by Bac-VP28, the
WSSV viral copy numbers were quantified in oral vaccinated
shrimp on different post-challenge days by quantitative real-time
PCR. The results indicated that WSSV VP26 gene copy numbers
increased in the Bac-VP28 groups until 6 dpi. The copy numbers
observed in the Bac-VP28 shrimp were significantly reduced to
3.7610
10 WSSV copies mg
21 by 10 dpi and then dropped to
1.42610
10 WSSV copies mg
21 by 15 dpi (Fig. 3a). In contrast, the
viral copy numbers in the Bac-wt and positive control groups
reached a peak level of 9.89610
10 WSSV copies mg
21 and above
of total DNA by 9 dpi before the shrimp succumbed to the virus.
The virus was not observed in the negative control group during
the experimental period. The viral copy numbers obtained in this
study are similar to the observations of Durand and Lightner [38],
who noted similar WSSV copy numbers (2.0610
4 to 10.2610
10
WSSV copies mg
21 of total DNA) after differing time intervals
post-WSSV infection in shrimp. In the present study, the reduced
viral copy numbers are possibly due to the activation of the innate
antiviral immunity system in the vaccinated shrimp. Also, our
immunohistochemistry results demonstrated that Bac-VP28 was
transduced effectively and expressed VP28 in the eye stalk and
hepatopancreas at 7 dpv (Fig. 3b). These results provide additional
evidence for the Bac-VP28 vaccine’s efficacy.
To support the vaccine efficacy generated by Bac-VP28, we
purposed to study the host gene response in the experimental
shrimp. There are increasing evidences postulated that defence
Figure 4. Temporal expression analysis LGBP and STAT genes in healthy or WSSV infected shrimp and compared with Bac-VP28
vaccinated shrimp at 2, 5, 7, 10 and 15 dpi. The relative expression level was expressed by DCt (Ct value of LGBP/STAT gene-Ct value of EF-1a
gene) and determined for each samples. The average DCt for WSSV infected or vaccinated samples from each days post infections was then used to
plot the graph.
doi:10.1371/journal.pone.0026428.g004
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Pattern Recognition Proteins (PRP) are those defense mechanism
molecules in invertebrates and plays major role to recognize and
responds to infections. LGBP is one of the effective PRP, and
responsible for the innate immune response in crustaceans and
insects by activating prophenoloxidase (proPO) cascade [39,40].
Roux et al. [32] compared expression level of LGBP gene in
healthy and WSSV challenge shrimp in different hours of post
infection. STAT is an another gene we chosen to study, because it
play a vital role in the innate immunity of both vertebrates and
invertebrates [41,42,43]. Janus Kinase (JAK)-STAT pathway
involved in the antiviral defense mechanism in invertebrates
[44,45]. Also, Chen et al. [33] studied the STAT gene expressions
in WSSV infected and PBS inoculated shrimp. So, we targeted to
analysis LGBP and STAT genes expressions at transcriptional
level in vaccinated shrimp challenged with WSSV using
quantitative real-time RT-PCR. In the present, we observed
LGBP gene was upregulated in WSSV infected shrimp propor-
tionally to progress of the infection. But, in the Bac-VP28
vaccinated shrimp, the expression level of LGBP gene upregulated
at early infections till at 7 dpi, later it downregulates at
considerable level. At 10 dpi, a significant different was observed
and WSSV infected shrimp showing higher expressions of LGBP
gene than vaccinated group (Fig. 4). The LGBP gene expression
level was statistically significant at (P,0.01) at 10 and 15 dpi. The
STAT gene expression analysis in the present study demonstrated
a similar level of expression patterns with earlier study [33] of
WSSV infected shrimp. In the vaccinated shrimp, the expression
trends is downregulated till 7 dpi, later it upregulated slowly and
reaches significant level at 15 dpi (Fig. 4). The STAT gene
expression level was statistically significant (P,0.01) at 10 and
15 dpi. As observed in this study, the changes in expression level in
LGBP and STAT genes postulated that, the recombinant
baculoviruses triggers innate immune response or efficiently decay
the WSSV viral particles upon challenge as seen in quantification
WSSV particles reduced at 15 dpi.
After examining the results of the present study, the WSSV
protection generated in shrimp may be explained in three ways.
First, the ability of ie1 promoter to transduce the VP28 efficiently
in the shrimp tissue and to expresses VP28 protein for an extended
duration may be involved. Similarly, Liu et al. [27], described that
shrimp STAT enhances the expression of ie1 promoter. The
promoter enhancement could indirectly activate the expression of
the VP28 in the baculovirus construct. Second, the display of
VP28 on the baculovirus surface theoretically makes it readily
accessible for the earlier interactions with the shrimp cell and helps
the cell to avoid further attachment of WSSV virions. A similar
idea was proposed by Yang et al. [46] for hemagglutinin (HA), the
viral envelope protein of influenza virus. The third explanation is
that the persistent infection of shrimp by the recombinant
baculovirus may reduce the severity of WSSV infection by an
unknown mechanism. Such a result is part of the ‘‘viral
accommodation’’ concept [47].
In summary, a novel approach was identified in which a
recombinant baculovirus was used as a potential vaccine candidate
for WSSV in shrimp. The ie1 promoter of WSSV was used to
efficiently express VP28 consistently in insect cells, and the
recombinant baculovirus is able to transduce and express VP28
successfully in shrimp cells without having any adverse effect on
the shrimp. As observed in the present study, the oral
administration of Bac-VP28 to shrimp generated a higher survival
rate compared with immersion or other forms of vaccination. In
addition, the good biosafety profile of the baculovirus as a vaccine
vector in both humans and shrimp make it an attractive choice.
Oral vaccination with recombinant baculovirus is an attractive
choice for vaccination of shrimp against WSSV. The results of the
present study open up new avenues in the development of novel
field-applicable vaccines.
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